Search results for " therapeutic" in Articles / App Notes
Article
Get Acquainted with How SPR Technology is Used for Better Protein Characterization
Surface plasmon resonance (SPR) has become a go-to tool for biotherapeutic characterization, and most approved antibody therapeutics have passed through a Biacore SPR system.
Stay up-to-date wit…
Article
Achieving Efficient Adenovirus Upstream Production
Adenovirus is one of the most frequently used viral vectors in the development of therapeutic vaccines and vaccines against infectious diseases. Adenovirus has also been explored as a viral vector f…
Article
Biopharma Says It Has an Evolution in New Technologies and Processes
Cytiva introduced prefabricated, modular KUBio manufacturing units for the production of viral vector-based therapeutics including viral-vector based vaccines, oncolytic viruses, and gene and cell the…
Article
Going Viral
The new KUBio BSL-2 solution for viral vector-based therapeutics, including oncolytic vaccines and cell and gene therapies allows manufacturers to quickly build a ready-to-run, prefabricated modular m…
Article
Biopharmaceutical Market in Asia: Q&A with Günter Jagschies, Strategic Customer Relations Leader, Cytiva
…nteract with Asian biopharmaceutical producers?
The sheer number of patients to be supplied with therapeutics and vaccines, often with insufficient support from health insurance, for example, and…
Article
QbD Improves Cell-Culture Process Control
QbD Improves Cell-Culture Process Control
A quality-by-design approach that implements PAT offers advantages in upstream cell-culture processing.
By Feliza Mirasol
Mar…
Article
Evaluation of HEK293 Cell Growth and Adenovirus Productivity in HyClone™ CDM4HEK293 Medium
HEK293 cells are susceptible to infection by adenovirus, one of the most frequently used viral vectors in the development of therapeutic vaccines and vaccines against infectious diseases. This applica…
Article
Bioburden Control in the Biopharmaceutical Industry
Conclusion
The biologics sector is continually expanding because these drugs demonstrate better therapeutic value in treating an increasing number of chronic diseases (18). Biologics manufacturing…
Article
Contract Manufacturing Through the Years
Finally, the impact of new therapeutic and manufacturing technologies bears close attention. New targeted therapies mean that the average volume per product is declining; even when more sophisticated …
Article
Hybrid Bioprocessing: A Q&A with Andrew Sinclair
In the therapeutic protein space, there has not been a truly SU facility at commercial scale.
What could be the main reasons and/or the main drivers that hybrid bioprocessing are being used? Is th…